Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma
pharmaceutical investing Advanced Proteome Therapeutics Announces Progress on Antibody-Radioisotope Conjugate Initiative
RZOLV Technologies Appoints Mary Ellen Thorburn to the Board of Directors; Announces the Retirement of Darryl Yea